2m Koreans opt out of life
Nearly two million individuals in Korea have formally declined life-extending medical interventions, choosing instead to prioritize their right to die with dignity when suffering from a terminal condition, data showed Sunday.
Data from the National Agency for Management of Life-Sustaining Treatment reveals that as of the end of August, 1,941,231 people have filed an advance health care directive to abstain from life-saving medical assistance since the system's inception in February 2018.
Women make up the majority of individuals opting for this choice, accounting for 68 percent, or 1,319,812, of those registered, with men accounting for the remaining 32 percent, or 621,419.
Less than 100,000 people registered for the health care directive in 2018. However, the number surged to 530,000 in 2019, 790,000 in 2020, 1,160,000 in 2021 and 1,570,000 in 2022.
Judging from the current monthly growth rate, the number is projected to exceed two million in October.
Five and half years have passed since the so-called "Death with Dignity Act" came into effect in Korea in February 2018. The act enabled people to refuse life-prolonging medical treatment.
Any adult over the age of 19 can register for the advance medical directive detailing treatment plans in the case of terminal illness, which they can also withdraw from at any time.
The necessary documents can be submitted to the National Agency for Management of Life-Sustaining Treatment, and the information will then be registered in a government database shared by hospitals and public health institutions. Life-sustaining treatment can be halted under several conditions if an individual falls terminally ill. The requirements include confirmation by a family member, approval from the ethics committee at a medical institution, and the agreement of the patient’s primary doctor and another doctor who is an expert in the field.
Currently, four types of treatment -- cardiopulmonary resuscitation, use of artificial respiration, hemodialysis and administration of anti-cancer drugs -- are categorized as life-extension care by the government.
(责任编辑:재무)
- Dansaekhwa master Park Seo
- 대통령실 “UAE 대통령 방한 순연”…이스라엘·하마스 충돌 영향
- [Herald Interview] Indonesia's Aladin Bank CEO eyes digital banking partnerships with Korea
- Conflict between Fifty Fifty and agency Attrakt continues to escalate
- S. Korea has 'no urgency' to cut key lending rate soon: IMF director
- NMK to extend support for Korean galleries at six museums abroad
- Korean economy expected to grow by 2.1% in 2024: Hana Institute
- Seoul shares dip 1 pct on Fed rate hike woes, won sharply slides
- Korean economy expected to grow by 2.1% in 2024: Hana Institute
- S Korea, UAE agree to increase bilateral flight ceiling to 21 per week
- [Today’s K
- Yoon says improved relations between S. Korea, Japan are people's will
- Kia to expand EV lineup with mass market appeal
- Chinese avant
- Kia to expand EV lineup with mass market appeal
- 기세 올린 이재명 체제…이번엔 한동훈 겨냥 공세 집중
- LS Cable inks partnership for Vietnam submarine cable market
- Political parties call for revision of military exemptions for athletes
- GS Caltex, Posco team up on biofuel
- 28th BIFF comes to an end
- LG Chem pivots to LFP with Huayou for Morocco plant views+
- [Test Drive] Toyota’s minivan Alphard boasts sedanlike drive views+
- BTS' Suga begins military service views+
- "가리비 8m 천장까지 쌓였다"…단 한달만에 日 타격 입힌 中 views+
- Ministry uncovers 1,802 Youth Protection Act violations views+
- Surveillance cameras to be a must in hospital operating rooms views+
- [New in Korean] Ancient Korean mummy unearthed in Irish peatland views+
- Seoul shares close lower amid woes over Fed's drawn views+
- [Korea Beyond Korea] 'Funding drought jeopardizes interest in ancient Korea studies in US' views+
- [Book Review] 'Lee Kun views+